Particle.news
Download on the App Store
3 ARTICLES
·
last wk.

Trump Orders DOJ To Seek Rescheduling Of Marijuana And CBD To Schedule III

The directive opens a DEA review that could expand medical research access, leaving federal criminal statutes unchanged.

Cannabis soll in den USA als weniger gefährliche Substanz eingestuft werden. US-Präsident Donald Trump unterzeichnete am Donnerstag in Washington ein Dekret, mit dem Cannabis nicht mehr Heroin, LSD oder Ecstasy gleichgestellt werden soll.
Image

Overview

  • President Trump signed a decree directing the Justice Department to initiate moving marijuana and CBD from Schedule I to Schedule III.
  • The change is not decriminalization, and federal prosecutions can continue, with officials noting repeat offenses can bring multi‑year prison terms and heavy fines.
  • Any reclassification requires DEA approval through its scientific review and rulemaking process, with timing not yet specified.
  • The shift from Schedule I to III is framed around recognized medical use and could ease research and attract investment, with cannabis stocks rising after the announcement.
  • More than 20 Republican senators urged keeping marijuana in Schedule I, citing health and safety risks, while many states already allow adult or medical use under their own laws.